(Q51725407)

English

Combined improvements in implantable pump technology and insulin stability allow safe and effective long term intraperitoneal insulin delivery in type 1 diabetic patients: the EVADIAC experience.

scientific article published in December 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/14707889

Combined improvements in implantable pump technology and insulin stability allow safe and effective long term intraperitoneal insulin delivery in type 1 diabetic patients: the EVADIAC experience. (English)

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/14707889

1 reference

based on heuristic

inferred from title

author name string

H Gin

1

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/14707889

E Renard

2

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/14707889

V Melki

3

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/14707889

S Boivin

4

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/14707889

P Schaepelynck-Bélicar

5

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/14707889

B Guerci

6

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/14707889

J L Selam

7

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/14707889

J M Brun

8

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/14707889

J P Riveline

9

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/14707889

B Estour

10

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/14707889

B Catargi

11

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/14707889

EVADIAC Study Group

12

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/14707889

publication date

1 December 2003

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/14707889

Diabetes and Metabolism

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/14707889

29

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/14707889

6

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/14707889

602-607

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/14707889

Implanted programmable insulin pumps: one hundred fifty-three patient years of surgical experience

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970075-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Feasibility of intraperitoneal insulin therapy with programmable implantable pumps in IDDM. A multicenter study. The EVADIAC Study Group. Evaluation dans le Diabète du Traitement par Implants Actifs

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970075-7

7 January 2021

based on heuristic

inferred from DOI database lookup

French multicentre experience of implantable insulin pumps. The EVADIAC Study Group. Evaluation of Active Implants in Diabetes Society

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970075-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin underdelivery from implanted pumps using peritoneal route. Determinant role of insulin pump compatibility

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970075-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of in vivo stability of a new insulin preparation for implantable insulin pumps. A randomized multicenter prospective trial. EVADIAC Group. Evaluation Dans le diabète du Traitement par Implants Actifs

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970075-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical evaluation of a newly designed compliant side port catheter for an insulin implantable pump: the EVADIAC experience. Evaluation dans le Diabete du Traitement par Implants Actifs

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970075-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A preliminary trial of the programmable implantable medication system for insulin delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970075-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical trial of programmable implantable insulin pump for type I diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970075-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuous intraperitoneal insulin infusion in patients with 'brittle' diabetes: favourable effects on glycaemic control and hospital stay.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970075-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Local adverse events associated with long-term treatment by implantable insulin pumps. The French EVADIAC Study Group experience. Evaluation dans le Diabète du Traitement par Implants Actifs

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970075-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of antigenicity of Hoechst 21PH insulin using either implantable intraperitoneal pump or subcutaneous external pump infusion in type 1 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970075-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970075-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1262-3636(07)70075-7

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/14707889

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/14707889

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51725407&oldid=1415688396"